Listenly

What was the price drop for oxaliplatin (Eloxatin) between 2012 and Q1 2026 after converting from brand to generic?

Answered at 5:29 in AH118 - Chemo, Cars, & Where Health Plan Savings May be Hiding, with Brian Cotter · The Astonishing Healthcare Podcast

— questions searchable right now

What was the price drop for oxaliplatin (Eloxatin) between 2012 and Q1 2026 after converting from brand to generic?

In 2012, oxaliplatin was a brand drug with an ASP price of $2,053 for a 200 milligram dose. By Q1 2026, the price dropped to $9.40, representing a drop of over 99%. However, price variation persists in the market—one hospital's website listed the drug at $29,595, while Medicare would reimburse less than ten dollars.

Brian Cotter on The Astonishing Healthcare PodcastAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

In 2012, oxaliplatin was a brand drug with an ASP price of $2,053 for a 200 milligram dose.

Brian Cotter, Founder at Bright Spot Insights · AH118 - Chemo, Cars, & Where Health Plan Savings May be Hiding, with Brian Cotter · The Astonishing Healthcare Podcast · answer at 5:29

Key takeaways

  • In 2012, oxaliplatin was a brand drug with an ASP price of $2,053 for a 200 milligram dose.

Quote to remember

“Assume the data is incorrect until proven otherwise. You need to work through the steps to validate the data before you can start digging in and understanding what price variation you see.”

— Brian Cotter

The full answer · about 5 min

In 2012, oxaliplatin was a brand drug with an ASP price of $2,053 for a 200 milligram dose. By Q1 2026, the price dropped to $9.40, representing a drop of over 99%. However, price variation persists in the market—one hospital's website listed the drug at $29,595, while Medicare would reimburse less than ten dollars.

Key facts

  • Oxaliplatin ASP price dropped from $2,053 in 2012 to $9.40 in Q1 2026—a 99% reduction
  • One hospital listed oxaliplatin at $29,595 compared to Medicare reimbursement under $10
  • Specialty drug spend now represents 55-60% of pharmacy spend
  • Pharmacy spend represents 25-30% of total plan spend
  • 431 drugs had price drops between Q1 2025 and Q1 2026, with drops up to 99%

People, companies and topics mentioned

Bright Spot InsightsMedicareASP (Average Sales Price)J code (J9263 for oxaliplatin/Eloxatin)Oxaliplatin (Eloxatan)Specialty drugs (oncology)Price transparency dataMedical benefit

More answers from this episode

 ·  All answers from The Astonishing Healthcare Podcast →
—
—
0:00
0:00